“Risk of Hepatitis B Reactivation in Rheumatic Patients Receiving Tocilizumab Treatment”. Annals of Medical Research 32, no. 11 (November 25, 2025): 512–517. Accessed December 2, 2025. http://www.annalsmedres.org/index.php/aomr/article/view/4880.